SlidesetViral Hepatitis and Liver DiseaseHEP DART 2017Looking back to move forward: designing next-gen RNAi for best results in HBV- Bruce GivenView Slideset
SlidesetViral Hepatitis and Liver DiseaseHEP DART 2017New directions towards functional cure of Chronic Hepatitis B- Lawrence Blatt, PhDView Slideset
FZFabien ZoulimMD, PhDSlidesetViral Hepatitis and Liver DiseaseHEP DART 2017Is there a best Direct Acting Antiviral in development?- Fabien Zoulim, MD, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseHEP DART 2017Is there a best immunomodulator in development?- Ulrike ProtzerView Slideset
SlidesetViral Hepatitis and Liver DiseaseHEP DART 2017Is There a Best Host Acting Antiviral for HBV Cure?- Jake LiangView Slideset
SlidesetViral Hepatitis and Liver DiseaseHEP DART 2017HEV Update: Diagnostics and Management- Kenneth Sherman, MD, PhDView Slideset
FZFabien ZoulimMD, PhDSlidesetViral Hepatitis and Liver DiseaseHEP DART 2017Revisiting the Molecular and Cell Biology of the Hepatitis B Virus Towards Elimination- Fabien Zoulim, MD, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseHEP DART 2017Emerging Therapeutic Targets and Concepts for Delta Hepatitis Virus (not yet available) - Jeffrey GlennView Slideset
SlidesetViral Hepatitis and Liver DiseaseHEP DART 2017A novel immunotherapy for chronic HBV and HDV infections that bypass tolerance and induce broadly crossreactive and neutralizing antibodies (not available)- Dr. M. SallbergView Slideset
SlidesetViral Hepatitis and Liver DiseaseHEP DART 2017Development of Immune Competent Small Animal Models for HBV- Helene Strick-MarchandView Slideset
